Contact us: info@cirsa.com.au

Cardiac Imaging Research SA

Our Research

 

 

The principal research focus of the group is the use Cardiovascular Magnetic Resonance imaging as research tool to investigate mechanisms and effect of heart disease.

 

We do this in 3 broad research areas:

  • Heart Failure and Cardiomyopathy,
  • Novel Myocardial Ischemia Techniques and
  • Assessment of Myocardial Protection.

Research lab

 
 

Articles

 

 

CMR GUIDE HF (Cardiac Magnetic Resonance GUIDEd management of mild moderate Heart Failure)

Current heart failure guidelines recommend insertion of implantable cardiac defibrillators (ICD) for primary prevention of sudden cardiac death (SCD) in patients whose left ventricular ejection fraction is (LVEF) ≤ 35% on maximally t...
 

Prognostic Utility of BOLD Cardiovascular Magnetic Resonance Imaging in Chronic Kidney Disease

Cardiovascular disease is common in patients with chronic kidney disease (CKD). Coronary artery disease (CAD) is a major cause of death in CKD patients. However, early disease can be asymptomatic.
 

Pulmonary Hypertension Study

This research project is testing a new method of detecting pulmonary hypertension (high lung pressures) using cardiac magnetic resonance imaging (sometimes called CMR) and dobutamine stress echocardiography (sometimes called DSE) . . .
 

ECHO SCAR: ECHOcardiographic Strain characteristic predictors of sudden CARdiac death

ECHO cardiographic S train characteristic predictors of sudden CAR diac death in mild to moderate Heart Failure (ECHO SCAR) Some patients with heart failure are at risk from sudden cardiac death due to a life threatening heart rhythm. This . . ...
 

Echocardiographic strain and mechanical dispersion for prediction of sudden cardiac death

Echocardiographic strain and mechanical dispersion for prediction of sudden cardiac death and malignant ventricular arrhythmias. Our prediction tools for working out who is a risk from sudden cardiac death are limited, particularly in ...
 

Identification of Atypical Fabry’s Disease in a Cardiac Population

Fabry’s Disease is a rare genetic disorder that affects many organ systems in the body including the kidneys, skin and the heart. The defect is due to a deficiency of an enzyme, which then leads to the accumulation of a sphingolipid ...
 

Chemotherapy Related Heart Effects

We have been actively conducting research in chemotherapy related heart effects. Our work has been in breast cancer patients. Based on the breast cancer, oncologist recommend a specific chemotherapy. While still very rare, important . . .
 

Statin Therapy in Ischaemia Reperfusion in Coronary Artery Bypass Grafting STIR

After prolonged ischaemia, there are reversibly damaged but viable cells that are further injured when blood flow is quickly restored to the heart. This phenomenon is called ischaemia-reperfusion injury (IRI). Evidence is mounting for . . .
 

CMR GUIDE HF (Cardiac Magnetic Resonance GUIDEd management of mild moderate Heart Failure)

Prognostic Utility of BOLD Cardiovascular Magnetic Resonance Imaging in Chronic Kidney Disease

Pulmonary Hypertension Study

ECHO SCAR: ECHOcardiographic Strain characteristic predictors of sudden CARdiac death

Echocardiographic strain and mechanical dispersion for prediction of sudden cardiac death

Identification of Atypical Fabry’s Disease in a Cardiac Population

Chemotherapy Related Heart Effects

Statin Therapy in Ischaemia Reperfusion in Coronary Artery Bypass Grafting STIR